Position in VTRS
as of Jun 30, 2026
· filed Aug 6, 2026
Position Value
$8,003
+$3,707 QoQ
Shares Held
504
+58.5% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#784
of 1,016 holders
Holding Since
Dec 2020
8 quarters on record
Common Shares in VTRS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026KELLEHER FINANCIAL ADVISORS holds $29,756 across 8 Drug Manufacturers - Specialty & Generic names. VTRS ranks #2 (26.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
166 | $11,928 | |
| 2 | VTRS |
Viatris Inc
This page
|
504 | $8,003 | |
| 3 | TAK |
Takeda Pharmaceutical Co Ltd
|
251 | $4,023 | |
| 4 | PCRX |
Pacira BioSciences, Inc.
|
76 | $1,928 | |
| 5 | EBS |
Emergent BioSolutions Inc.
|
207 | $1,734 | |
| 6 | HLN |
Haleon plc
|
148 | $1,380 | |
| 7 | SHPH |
Shuttle Pharmaceuticals Holdings, Inc.
|
120 | $390 | |
| 8 | ELTP |
Elite Pharmaceuticals Inc /Nv/
|
1,000 | $370 |
All Filings in VTRS
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $8,003 | 504 | Shares | Sole | 2026-08-06 | |
| 2026-03-31 | $4,296 | 318 | Shares | Sole | 2026-05-08 | |
| 2025-12-31 | $3,958 | 318 | Shares | Sole | 2026-01-20 | |
| 2025-09-30 | $3,148 | 318 | Shares | Sole | 2025-11-14 | |
| 2021-09-30 | $419,684 | 30,973 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $405,721 | 28,392 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $407,630 | 29,179 | Shares | Sole | 2021-05-13 | |
| 2020-12-31 | $488,907 | 26,089 | Shares | Sole | 2021-02-12 | |
| No filing history on record for this holder in this stock. | ||||||